Overview

Congress overhauled FDA’s regulatory framework for cosmetics as part of the Consolidated Appropriations Act of 2023. The Modernization of Cosmetics Regulation Act (MoCRA) gave new regulatory authorities to FDA under Chapter VI of the Federal Food, Drug, and Cosmetic Act (FD&C Act). In this webinar, speakers will discuss the new regulatory framework for cosmetics and key provisions for the cosmetics industry, such as facility registration, product listing, mandatory adverse reporting, safety substantiation, mandatory allergen labeling, mandatory recall authority, and current good manufacturing practices (CGMPs) for cosmetics.

Speakers

Surya Kundu, Associate, Steptoe & Johnson LLP
Anand Natajaran, Associate Counsel, Estee Lauder Companies
Linda M. Katz, Director, Office of Cosmetics and Color, FDA-CFSAN
Moderated by Jessica O’ Connell, Partner, Covington & Burling LLP